Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Navigation/Search

Selected Publication:

SHR Neuro Cancer Cardio Lipid Metab Microb

Tang, Z; Xie, H; Heier, C; Huang, J; Zheng, Q; Eichmann, TO; Schoiswohl, G; Ni, J; Zechner, R; Ni, S; Hao, H.
Enhanced monoacylglycerol lipolysis by ABHD6 promotes NSCLC pathogenesis.
EBioMedicine. 2020; 53: 102696 Doi: 10.1016/j.ebiom.2020.102696 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

Co-authors Med Uni Graz: Eichmann Thomas; Schoiswohl Gabriele Maria
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):
Abstract:: BACKGROUND: Tumor cells display metabolic changes that correlate with malignancy, including an elevated hydrolysis of monoacylglycerol (MAG) in various cancer types. However, evidence is absent for the relationship between MAG lipolysis and NSCLC. METHODS: MAG hydrolase activity assay, migration, invasion, proliferation, lipids quantification, and transactivation assays were performed in vitro. Tumor xenograft studies and lung metastasis assays were examined in vivo. The correlations of MAGL/ABHD6 expression in cancerous tissues with the clinicopathological characteristics and survival of NSCLC patients were validated. FINDINGS: ABHD6 functions as the primary MAG lipase and an oncogene in NSCLC. MAG hydrolase activities were more than 11-fold higher in cancerous lung tissues than in paired non-cancerous tissues derived from NSCLC patients. ABHD6, instead of MAGL, was significantly associated with advanced tumor node metastasis (TNM) stage (HR, 1.382; P = 0.004) and had a negative impact on the overall survival of NSCLC patients (P = 0.001). ABHD6 silencing reduced migration and invasion of NSCLC cells in vitro as well as metastatic seeding and tumor growth in vivo. Conversely, ectopic overexpression of ABHD6 provoked the pathogenic potential. ABHD6 blockade significantly induced intracellular MAG accumulation which activated PPARα/γ signaling and inhibited cancer pathophysiology. INTERPRETATION: The present study provide evidence for a previously uncovered pro-oncogenic function of ABHD6 in NSCLC, with the outlined metabolic mechanisms shedding light on new potential strategies for anticancer therapy. FUND: This work was supported by the Project for Major New Drug Innovation and Development (2015ZX09501010 and 2018ZX09711001-002-003).
Find related publications in this database (using NLM MeSH Indexing): A549 Cells - administration & dosage; Adult - administration & dosage; Aged - administration & dosage; Aged, 80 and over - administration & dosage; Animals - administration & dosage; Carcinoma, Non-Small-Cell Lung - genetics, metabolism, pathology; Female - administration & dosage; Humans - administration & dosage; Lipolysis - administration & dosage; Lung Neoplasms - genetics, metabolism, pathology; Male - administration & dosage; Mice - administration & dosage; Mice, Inbred BALB C - administration & dosage; Mice, Nude - administration & dosage; Mice, SCID - administration & dosage; Middle Aged - administration & dosage; Monoacylglycerol Lipases - genetics, metabolism; Monoglycerides - metabolism
Find related publications in this database (Keywords): NSCLC; ABHD6; Aggressiveness; MAG